v3.20.1
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Income Statement [Abstract]    
Revenues
Operating expenses:    
Research and development 1,449,872 1,371,848
General and administrative 1,831,621 1,456,197
Total operating expenses 3,281,493 2,828,045
Operating loss (3,281,493) (2,828,045)
Other income (expense):    
Interest income 35,449 94,405
Interest expense (77,836) (76,981)
Equity modification expense (802,400)  
Amortization of debt discount and offering costs (91,283) (109,963)
Total other expense (936,070) (92,539)
Net loss $ (4,217,563) $ (2,920,584)
Basic and diluted net loss per share $ (0.10) $ (0.07)
Weighted average common shares outstanding - basic and diluted 43,119,369 42,635,509

Source